These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25420222)

  • 21. Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores.
    McDuffie A; Thurman AJ; Hagerman RJ; Abbeduto L
    J Autism Dev Disord; 2015 Jul; 45(7):1925-37. PubMed ID: 24414079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
    Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
    Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TMS: using the theta-burst protocol to explore mechanism of plasticity in individuals with Fragile X syndrome and autism.
    Oberman LM; Horvath JC; Pascual-Leone A
    J Vis Exp; 2010 Dec; (46):. PubMed ID: 21248685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence and rate of autism in fragile X syndrome across the first years of life.
    Roberts JE; Bradshaw J; Will E; Hogan AL; McQuillin S; Hills K
    Dev Psychopathol; 2020 Oct; 32(4):1335-1352. PubMed ID: 33161907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social communication and theory of mind in boys with autism and fragile x syndrome.
    Losh M; Martin GE; Klusek J; Hogan-Brown AL; Sideris J
    Front Psychol; 2012; 3():266. PubMed ID: 22934085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008).
    Brodkin ES
    Behav Neurosci; 2008 Apr; 122(2):483-9. PubMed ID: 18410188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments.
    Salcedo-Arellano MJ; Cabal-Herrera AM; Punatar RH; Clark CJ; Romney CA; Hagerman RJ
    Neurotherapeutics; 2021 Jan; 18(1):265-283. PubMed ID: 33215285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain function and gaze fixation during facial-emotion processing in fragile X and autism.
    Dalton KM; Holsen L; Abbeduto L; Davidson RJ
    Autism Res; 2008 Aug; 1(4):231-9. PubMed ID: 19360673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
    Berry-Kravis E
    Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autism in fragile X syndrome: a category mistake?
    Hall SS; Lightbody AA; Hirt M; Rezvani A; Reiss AL
    J Am Acad Child Adolesc Psychiatry; 2010 Sep; 49(9):921-33. PubMed ID: 20732628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragile X syndrome and autism at the intersection of genetic and neural networks.
    Belmonte MK; Bourgeron T
    Nat Neurosci; 2006 Oct; 9(10):1221-5. PubMed ID: 17001341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.
    Westmark CJ; Sokol DK; Maloney B; Lahiri DK
    Mol Psychiatry; 2016 Oct; 21(10):1333-41. PubMed ID: 27573877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered brain-wide auditory networks in a zebrafish model of fragile X syndrome.
    Constantin L; Poulsen RE; Scholz LA; Favre-Bulle IA; Taylor MA; Sun B; Goodhill GJ; Vanwalleghem GC; Scott EK
    BMC Biol; 2020 Sep; 18(1):125. PubMed ID: 32938458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomic regulation in fragile X syndrome.
    Heilman KJ; Harden ER; Zageris DM; Berry-Kravis E; Porges SW
    Dev Psychobiol; 2011 Dec; 53(8):785-95. PubMed ID: 21547900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study.
    Hong MP; Eckert EM; Pedapati EV; Shaffer RC; Dominick KC; Wink LK; Sweeney JA; Erickson CA
    J Neurodev Disord; 2019 Jan; 11(1):1. PubMed ID: 30665413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic variability to medication management: an update on fragile X syndrome.
    Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
    Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of cerebellar vermian abnormalities in autism: a quantitative magnetic resonance imaging study.
    Kaufmann WE; Cooper KL; Mostofsky SH; Capone GT; Kates WR; Newschaffer CJ; Bukelis I; Stump MH; Jann AE; Lanham DC
    J Child Neurol; 2003 Jul; 18(7):463-70. PubMed ID: 12940651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome.
    Lee M; Martin GE; Berry-Kravis E; Losh M
    J Neurodev Disord; 2016; 8():47. PubMed ID: 28050218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associating neural alterations and genotype in autism and fragile x syndrome: incorporating perceptual phenotypes in causal modeling.
    Bertone A; Hanck J; Kogan C; Chaudhuri A; Cornish K
    J Autism Dev Disord; 2010 Dec; 40(12):1541-8. PubMed ID: 20872060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.